In vitro metabolism of cyclosporine A by human kidney CYP3A5
- 1 November 2004
- journal article
- Published by Elsevier BV in Biochemical Pharmacology
- Vol. 68 (9), 1889-1902
- https://doi.org/10.1016/j.bcp.2004.07.012
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Association between ABCB1 (multidrug resistance transporter) genotype and post-liver transplantation renal dysfunction in patients receiving calcineurin inhibitorsPharmacogenetics, 2003
- Chronic Renal Failure after Transplantation of a Nonrenal OrganNew England Journal of Medicine, 2003
- Chronic renal dysfunction late after liver transplantationLiver Transplantation, 2002
- END-STAGE RENAL DISEASE (ESRD) AFTER ORTHOTOPIC LIVER TRANSPLANTATION (OLTX) USING CALCINEURIN-BASED IMMUNOTHERAPY1Transplantation, 2001
- End-stage renal disease in liver transplantsClinical Transplantation, 2001
- Unique changes in interstitial extracellular matrix composition are associated with rejection and cyclosporine toxicity in human renal allograft biopsiesAmerican Journal of Kidney Diseases, 1999
- Apoptosis and necrosis: Mechanisms of cell death induced by cyclosporine A in a renal proximal tubular cell lineKidney International, 1998
- CHRONIC RENAL FAILURE FOLLOWING LIVER TRANSPLANTATIONTransplantation, 1998
- Alternative cyclosporine metabolic pathways and toxicityClinical Biochemistry, 1995
- COMPARISON OF THE EFFECTS OF CYCLOSPORINE AND ITS METABOLITES ON THE RELEASE OF PROSTACYCLIN AND ENDOTHELIN FROM MESANGIAL CELLSTransplantation, 1992